From The Daily Scan: St. Paul’s Hospital researcher receives $3.5 million for COVID-19 drug trial

Jun 25, 2020 | News

Dr. Jim Russell and his research team have just received $3.5 million to conduct a multi-site drug trial.Dr. Jim Russell and his research team have just received $3.5 million to conduct a multi-site drug trial.

A research team based at St. Paul’s Hospital has received new federal funding to continue investigating the effect of an existing class of drug on COVID-19.

Led by Dr. James Russell, a Principal Investigator at the Centre for Heart Lung Innovation, the team just received $3.5 million from the Canadian Institutes of Health Research (CIHR) for a multi-site clinical trial to study the safety and effectiveness of Losartan – a drug commonly prescribed for high blood pressure and diabetes – to treat COVID-19.

Read the full story on The Daily Scan.

Add new comment